Sort
21,281 grants matching “influenza”
Development of DAS181 (Fludase^) as a Broad Spectrum Therapeutic Agent
$9,999,863Mang Yu · Nexbio, Inc. · N01 · FY2009 · AI
Development of DAS181 (Fludase^) as a Broad Spectrum Therapeutic Agent
$9,999,165Mang Yu · Nexbio, Inc. · N01 · FY2010 · AI
ANTICIPATING INFLUENZA RESISTANCE EVOLUTION (AIRE): PATHWAYS AND STRATEGIES
$9,982,624University Of Massachusetts Medical School · · FY2015 · Department of Defense
Influenza, ILI and Emerging Infectious Diseases
$9,900,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Convalescent Plasma to Limit Coronavirus Associated Complications
$9,843,178David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2021 · TR
RAPID ACCELERATION OF DIAGNOSTICS ( RADX) PROGRAM: TECH PROJECT #2322 MICROGEM (MICROLAB)
$9,806,000Stuart Hellyar Hellyar · · N02 · FY2022 · HL
RADX TECH - TALIS BIOMEDICAL HIGHLY SCALABLE SARS-COV-2 RNA DETECTION IN MINUTES
$9,750,000Jennifer Baldwin · · N02 · FY2021 · HL
Infectious Disease Clinical Research Program
$9,644,009National Institute Of Allergy And Infectious Diseases · Y01 · FY2009 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$9,616,028Anna Wald · University Of Washington · UM1 · FY2020 · AI
Regulatory Support Services
$9,481,022Jerome Pierson · National Institute Of Allergy And Infectious Diseases · ZID · FY2015 · AI
Core A: Administrative Core
$9,202,226Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Inter- and Intra-Species Comparative Sequencing
$9,135,194James C Mullikin · National Human Genome Research Institute · ZIB · FY2016 · HG
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE
$9,112,616Matthew Johnson · Duke University · N01 · FY2022 · AI
Structure-based design of broadly protective coronavirus vaccines
$9,065,441Neil King · University Of Washington · P01 · FY2022 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$9,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2012 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$8,973,548National Institute Of Allergy And Infectious Diseases · Y01 · FY2014 · AI
Programmable antivirals: Targeting viral RNA secondary structures with LNAs and small molecules
$8,915,196Jeffrey S Glenn · Stanford University · U19 · FY2022 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA AND SURVEILLANCE
$8,914,566John J Treanor · · N01 · FY2007 · AI
Immune responses in the elderly to infection or vaccination
$8,878,891Rita Manfre · Wistar Institute · N01 · FY2011 · AI
Development/production of universal influenza vaccines
$8,780,594Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2024 · AI
INFLUENZA SURVEILLANCE AND RESEARCH
$8,761,547Marguerite Pappaioanou · · N01 · FY2007 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER
$8,741,423Tony Moody · Duke University · N01 · FY2020 · AI
ARRA: Clinical Support for Universal Influenza Development
$8,654,779Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$8,457,647Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2023 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$8,427,829David S Stephens · Emory University · UM1 · FY2025 · AI